HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
C P Belani Selected Research
C P Belani Research Topics
Disease
19
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2017 - 04/2000
3
Neutropenia
09/2013 - 06/2000
2
Exanthema (Rash)
09/2013 - 05/2005
2
Small Cell Lung Carcinoma (Small Cell Lung Cancer)
02/2004 - 05/2001
2
Lung Neoplasms (Lung Cancer)
05/2001 - 08/2000
1
Disease Progression
01/2017
1
Pneumonia (Pneumonitis)
09/2013
1
Esophagitis
09/2013
1
Fatigue
01/2013
1
Hyponatremia
01/2013
1
Neoplasm Metastasis (Metastasis)
01/2013
1
Neoplasms (Cancer)
11/2009
1
Carcinoma (Carcinomatosis)
11/2001
1
Febrile Neutropenia
06/2000
1
Wilms Tumor (Wilm's Tumor)
04/2000
Drug/Important Bio-Agent (IBA)
10
Paclitaxel (Taxol)
FDA Link
Generic
01/2013 - 04/2000
6
Carboplatin (JM8)
FDA Link
Generic
01/2013 - 06/2000
5
Cisplatin (Platino)
FDA Link
Generic
07/2005 - 04/2000
4
Docetaxel (Taxotere)
FDA Link
12/2000 - 04/2000
3
Gemcitabine
FDA Link
03/2010 - 12/2000
2
Platinum
IBA
01/2017 - 01/2007
2
Topotecan (Hycamtin)
FDA Link
Generic
02/2004 - 05/2001
1
Immuvac
IBA
01/2017
1
taxane
IBA
01/2017
1
Cetuximab (Erbitux)
FDA Link
09/2013
1
Pemetrexed (MTA)
FDA Link
06/2013
1
Integrins
IBA
01/2013
1
volociximab
IBA
01/2013
1
Biomarkers (Surrogate Marker)
IBA
01/2013
1
belotecan
IBA
11/2009
1
Etoposide (VP 16)
FDA Link
Generic
07/2005
1
Gefitinib (Iressa)
FDA Link
05/2005
1
Irinotecan (Camptosar)
FDA Link
Generic
05/2001
1
Topoisomerase I Inhibitors
IBA
05/2001
1
Filgrastim (Neupogen)
FDA Link
06/2000
1
Liposomes (Liposome)
IBA
05/2000
1
Superoxide Dismutase
IBA
05/2000
1
Platinum Compounds (Compounds, Platinum)
IBA
04/2000
1
Taxoids (Taxanes)
IBA
04/2000
Therapy/Procedure
7
Drug Therapy (Chemotherapy)
01/2017 - 04/2000
6
Therapeutics
01/2017 - 06/2000
1
Consolidation Chemotherapy
09/2013
1
Radiotherapy
09/2013
1
TP protocol
12/2000
1
Thoracotomy
08/2000
1
Minimally Invasive Surgical Procedures
08/2000
1
Chemoradiotherapy
05/2000
1
Combined Modality Therapy
04/2000